he 2030 Agenda for Sustainable Development adopted by countries at the United Nations in 2015 sets forth a comprehensive vision of development with 17 Sustainable Development Goals (SDGs) and 169 targets across all aspects of society [1]. The 2030 Agenda document is ambitious and explicit about the need for integrated and sustained action across society to address complex challenges such as ending extreme poverty, reducing widening economic inequality, tackling climate change, and reducing and preventing conflict.

Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually. The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., respectively. These parasites have similar biology and genomic sequence, suggesting that all three diseases could be cured with drug(s) modulating the activity of a conserved parasite target. However, no such molecular targets or broad spectrum drugs have been identified to date.

Human African trypanosomiasis (HAT), also known as sleeping sickness, is a neglected disease that impacts 70 million people distributed over 1.55 million km2 in sub-Saharan Africa and includes at least 50% of the population of the Democratic Republic of the Congo. Trypanosoma brucei gambiense accounts for more than 98% of the infections in central and West Africa, the remaining infections being from Trypanosoma brucei rhodesiense in East Africa. The parasites are transmitted to the hosts through the bite of an infected tsetse fly.

Tsetse flies are the sole vectors of human African trypanosomiasis throughout sub-Saharan Africa. Both sexes of adult tsetse feed exclusively on blood and contribute to disease transmission. Notable differences between tsetse and other disease vectors include obligate microbial symbioses, viviparous reproduction, and lactation. Here, we describe the sequence and annotation of the 366-megabase Glossina morsitans morsitans genome.

Human African trypanosomiasis, better known as sleeping sickness, nowadays ranks among the more neglected diseases in the countries of Africa where it is found. Though it still kills many people every year, it cannot compete for celebrity with such major killers as malaria and AIDS. Yet that was not always the case. A hundred years ago, sleeping sickness attracted considerable scientific research and political attention because of its importance to the conquest of sub-Saharan Africa by the European colonial powers.

Human African trypanosomiasis (HAT), also known as sleeping sickness, is a neglected disease that impacts 70 million people distributed over 1.55 million km2 in sub-Saharan Africa. Trypanosoma brucei gambiense accounts for almost 90% of the infections in central and western Africa, the remaining infections being from T. b. rhodesiense in eastern Africa. Furthermore, the animal diseases caused by related parasites inflict major economic losses to countries already strained. The parasites are transmitted to the mammalian hosts through the bite of an infected tsetse fly. Know More: http://www.ploscollections.org/article/browse/issue/info%3Adoi%2F10.1371...